204 related articles for article (PubMed ID: 12647210)
1. CD95 (Fas/APO-1)/CD95L in the gastrointestinal tract: fictions and facts.
Sträter J; Möller P
Virchows Arch; 2003 Mar; 442(3):218-25. PubMed ID: 12647210
[TBL] [Abstract][Full Text] [Related]
2. CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis.
Sträter J; Wellisch I; Riedl S; Walczak H; Koretz K; Tandara A; Krammer PH; Möller P
Gastroenterology; 1997 Jul; 113(1):160-7. PubMed ID: 9207274
[TBL] [Abstract][Full Text] [Related]
3. CD95 is cytoprotective for intestinal epithelial cells in colitis.
Park SM; Chen L; Zhang M; Ashton-Rickardt P; Turner JR; Peter ME
Inflamm Bowel Dis; 2010 Jun; 16(6):1063-70. PubMed ID: 20049944
[TBL] [Abstract][Full Text] [Related]
4. Paneth cells express high levels of CD95 ligand transcripts: a unique property among gastrointestinal epithelia.
Möller P; Walczak H; Reidl S; Sträter J; Krammer PH
Am J Pathol; 1996 Jul; 149(1):9-13. PubMed ID: 8686766
[TBL] [Abstract][Full Text] [Related]
5. Induction of murine hepatocyte death by membrane-bound CD95 (Fas/APO-1)-ligand: characterization of an in vitro system.
Schlosser SF; Azzaroli F; Dao T; Hingorani R; Crispe IN; Boyer JL
Hepatology; 2000 Oct; 32(4 Pt 1):779-85. PubMed ID: 11003622
[TBL] [Abstract][Full Text] [Related]
6. Clonal deletion of major histocompatibility complex class I-restricted CD4+CD8+ thymocytes in vitro is independent of the CD95 (APO-1/Fas) ligand.
Müller KP; Mariani SM; Matiba B; Kyewski B; Krammer PH
Eur J Immunol; 1995 Oct; 25(10):2996-9. PubMed ID: 7589104
[TBL] [Abstract][Full Text] [Related]
7. Differential and mutually exclusive expression of CD95 and CD95 ligand in epithelia of normal pancreas and chronic pancreatitis.
Hasel C; Rau B; Perner S; Sträter J; Möller P
Lab Invest; 2001 Mar; 81(3):317-26. PubMed ID: 11310825
[TBL] [Abstract][Full Text] [Related]
8. CD95/Fas signaling in human melanoma cells: conditional expression of CD95L/FasL overcomes the intrinsic apoptosis resistance of malignant melanoma and inhibits growth and progression of human melanoma xenotransplants.
Eberle J; Fecker LF; Hossini AM; Wieder T; Daniel PT; Orfanos CE; Geilen CC
Oncogene; 2003 Dec; 22(57):9131-41. PubMed ID: 14668794
[TBL] [Abstract][Full Text] [Related]
9. Peripheral T and putative natural killer cell lymphomas commonly coexpress CD95 and CD95 ligand.
Ng CS; Lo ST; Chan JK
Hum Pathol; 1999 Jan; 30(1):48-53. PubMed ID: 9923926
[TBL] [Abstract][Full Text] [Related]
10. Impaired CD95 expression predisposes for recurrence in curatively resected colon carcinoma: clinical evidence for immunoselection and CD95L mediated control of minimal residual disease.
Sträter J; Hinz U; Hasel C; Bhanot U; Mechtersheimer G; Lehnert T; Möller P
Gut; 2005 May; 54(5):661-5. PubMed ID: 15831912
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis by IFNgamma in human neuroblastoma cell lines through the CD95/CD95L autocrine circuit.
Bernassola F; Scheuerpflug C; Herr I; Krammer PH; Debatin KM; Melino G
Cell Death Differ; 1999 Jul; 6(7):652-60. PubMed ID: 10453076
[TBL] [Abstract][Full Text] [Related]
12. CD95 ligand: lethal weapon against malignant glioma?
Weller M; Kleihues P; Dichgans J; Ohgaki H
Brain Pathol; 1998 Apr; 8(2):285-93. PubMed ID: 9546287
[TBL] [Abstract][Full Text] [Related]
13. Immune evasion by tumours: involvement of the CD95 (APO-1/Fas) system and its clinical implications.
Strand S; Galle PR
Mol Med Today; 1998 Feb; 4(2):63-8. PubMed ID: 9547792
[TBL] [Abstract][Full Text] [Related]
14. Lens epithelial cells express CD95 and CD95 ligand treatment induces cell death and DNA fragmentation in vitro.
Hueber A; Eichholtz CD; Kociok N; Esser JM; Esser PJ
Eur J Ophthalmol; 2003 Apr; 13(3):241-5. PubMed ID: 12747644
[TBL] [Abstract][Full Text] [Related]
15. Mice lacking functional CD95-ligand display reduced proliferation of the intestinal epithelium without gross homeostatic alterations.
Trumpi K; Steller EJ; de Leng WW; Raats DA; Nijman IJ; Morsink FH; Borel Rinkes IH; Kranenburg O
Med Mol Morphol; 2016 Jun; 49(2):110-8. PubMed ID: 26700225
[TBL] [Abstract][Full Text] [Related]
16. Stromal derived factor-1 alpha (SDF-1 alpha) induces CD4+ T cell apoptosis via the functional up-regulation of the Fas (CD95)/Fas ligand (CD95L) pathway.
Colamussi ML; Secchiero P; Gonelli A; Marchisio M; Zauli G; Capitani S
J Leukoc Biol; 2001 Feb; 69(2):263-70. PubMed ID: 11272277
[TBL] [Abstract][Full Text] [Related]
17. Apoptosis in neuroblastomas induced by interferon-gamma involves the CD95/CD95L pathway.
Annicchiarico-Petruzzelli M; Bernassola F; Lovat PE; Redfern CP; Pearson AD; Melino G
Med Pediatr Oncol; 2001 Jan; 36(1):115-7. PubMed ID: 11464861
[TBL] [Abstract][Full Text] [Related]
18. Production and pro-apoptotic activity of soluble CD95 ligand in pancreatic carcinoma.
Bellone G; Smirne C; Carbone A; Mareschi K; Dughera L; Farina EC; Alabiso O; Valente G; Emanuelli G; Rodeck U
Clin Cancer Res; 2000 Jun; 6(6):2448-55. PubMed ID: 10873098
[TBL] [Abstract][Full Text] [Related]
19. Different susceptibility of cytotoxic T cells to CD95 (Fas/Apo-1) ligand-mediated cell death after activation in vitro versus in vivo.
Ehl S; Hoffmann-Rohrer U; Nagata S; Hengartner H; Zinkernagel R
J Immunol; 1996 Apr; 156(7):2357-60. PubMed ID: 8786290
[TBL] [Abstract][Full Text] [Related]
20. The role of CD95 and CD95 ligand in cancer.
Peter ME; Hadji A; Murmann AE; Brockway S; Putzbach W; Pattanayak A; Ceppi P
Cell Death Differ; 2015 Apr; 22(4):549-59. PubMed ID: 25656654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
